← FDA DRUG APPROVALS

FDA ANDA · ANDA065167

CYCLOSPORINE

Sponsor: PHARM ASSOC

APPLICATION
ANDA065167
TYPE
ANDA
ORIGINAL APPROVAL
2005-01-05
LATEST ACTION
2020-07-27
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

CYCLOSPORINEDiscontinued
CYCLOSPORINE 100MG/ML · SOLUTION · ORAL

Approval history

2020-07-27Labeling · Supplement 15 · standardAP
2010-11-18Labeling · Supplement 11AP
2009-12-09Labeling · Supplement 9AP
2008-07-17Labeling · Supplement 6AP
2006-06-20Labeling · Supplement 2AP
2005-11-29Labeling · Supplement 1AP
2005-01-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →